Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials

Circulation. Cardiovascular Interventions
Aaron M FromCharanjit S Rihal

Abstract

Contrast-induced nephropathy (CIN) is associated with significant morbidity and mortality. The objective of our meta-analysis was to assess the efficacy of iodixanol compared with low-osmolar contrast media (LOCM) for prevention of CIN. We searched MEDLINE, the Cochrane Central Register of Controlled Trials, and internet sources of cardiology trial results for individual and relevant reviews of randomized, controlled trials, for the terms contrast media, contrast nephropathy, renal failure, iodixanol, Visipaque, and low-osmolar contrast media. All studies reported an incidence rate of CIN for each study group; there was no restriction on the definition of CIN. There were no restrictions on journal type or patient population. Overall, 36 trials were identified for analysis of aggregated summary data on 7166 patients; 3672 patients received iodixanol and 3494 patients received LOCM. Overall, iodixanol showed no statistically significant reduction in CIN incidence below that observed with heterogeneous comparator agents (P=0.11). Analysis of patient subgroups revealed that there was a significant benefit of iodixanol when compared with iohexol alone (odds ratio, 0.25; 95% confidence interval, 0.11 to 0.55; P<0.001) but not when co...Continue Reading

References

Sep 1, 1995·The British Journal of Radiology·P VerowP Kjaersgaard
Jul 1, 1994·The American Journal of Cardiology·J A HillJ A Brinker
Sep 1, 1996·Academic Radiology·V C PoirierW R Nemzek
Dec 31, 1997·The American Journal of Medicine·P A McCulloughW W O'Neill
Jan 7, 2000·The British Journal of Radiology·N Chalmers, R W Jackson
Jan 25, 2003·BMJ : British Medical Journal·Douglas G Altman, J Martin Bland
Feb 7, 2003·The New England Journal of Medicine·Peter AspelinUNKNOWN Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators
May 20, 2004·JAMA : the Journal of the American Medical Association·Gregory J MertenThomas P Kennedy
Nov 3, 2004·Journal of the American College of Cardiology·Micha MaederHans Rickli
Jun 30, 2006·The New England Journal of Medicine·Giancarlo MarenziAntonio L Bartorelli
Aug 15, 2006·Journal of the American College of Cardiology·Peter A McCulloughFulvio Stacul
Sep 5, 2006·The American Journal of Cardiology·Charles DavidsonUNKNOWN CIN Consensus Working Panel
Feb 28, 2008·Investigative Radiology·Henrik S ThomsenUNKNOWN Investigators in the Abdominal Computed Tomography: IOMERON 400 Versus VISIPAQUE 320 Enhancement (ACTIVE) Study
Apr 17, 2008·Journal of Diabetes and Its Complications·Kathy J HardiekCharles E Katholi
Oct 3, 2008·Mayo Clinic Proceedings·Aaron M FromFurman S McDonald
Dec 25, 2009·Circulation. Cardiovascular Interventions·Rainer WesselyUNKNOWN Contrast Media and Nephrotoxicity Following Coronary Revascularization by Angioplasty Trial Investigators

❮ Previous
Next ❯

Citations

Jan 24, 2012·European Heart Journal·Erdmann SeeligerPontus B Persson
Feb 4, 2014·International Journal of Technology Assessment in Health Care·Sergio IannazzoMassimo Valentino
Mar 4, 2014·BioMed Research International·Richard Solomon
Apr 8, 2014·BioMed Research International·Erdmann SeeligerPontus B Persson
Jun 5, 2014·BioMed Research International·Michele AndreucciAdis Tasanarong
May 9, 2014·BioMed Research International·Ulla Ludwig, Frieder Keller
Aug 19, 2015·The Canadian Journal of Cardiology·Lorenzo AzzaliniHung Q Ly
Jan 24, 2014·Journal of Interventional Cardiology·Owen MogabgabEmmanouil S Brilakis
Nov 26, 2011·The American Journal of Medicine·Amir B Rabbani, Brahmajee K Nallamothu
Mar 2, 2016·Annales de cardiologie et d'angéiologie·V SpagnoliH Q Ly
Mar 3, 2015·AJR. American Journal of Roentgenology·Matthew S DavenportJames H Ellis
Feb 8, 2014·International Journal of Cardiology·Giuseppe Biondi-ZoccaiGiacomo Frati
Apr 29, 2015·Singapore Medical Journal·Kheng Song LeowCher Heng Tan
Oct 23, 2012·Vascular Pharmacology·Egeria ScodittiMaria Rosa Montinari
May 7, 2014·BioMed Research International·Andreas M BucherRichard W Katzberg
Sep 5, 2014·Thyroid : Official Journal of the American Thyroid Association·Michael W YehUNKNOWN American Thyroid Association Surgical Affairs Committee Writing Task Force
May 29, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Steven D Weisbord, Paul M Palevsky
Dec 4, 2014·Korean Circulation Journal·Soo Yong LeeJune Hong Kim
Oct 6, 2011·Circulation. Cardiovascular Interventions·Mauro MaioliFrancesco Bellandi
Oct 15, 2014·Current Opinion in Critical Care·Wim VandenbergheEric A J Hoste
Dec 4, 2014·American Journal of Therapeutics·Luis M OrtegaAli Nayer
Apr 11, 2012·Investigative Radiology·Stefan HanederHenrik Jakob Michaely
Jan 9, 2016·Clinical and Experimental Pharmacology & Physiology·Barry Hogstrom, Nobuhiro Ikei

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.